Atherogenic index of plasma, lipid accumulation and visceral adiposity in metabolic syndrome patients.
Metabolic syndrome
Diabetes Mellitus
adiposity index
atherogenic index
Journal
Bioinformation
ISSN: 0973-2063
Titre abrégé: Bioinformation
Pays: Singapore
ID NLM: 101258255
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
11
2022
revised:
29
11
2022
accepted:
30
11
2022
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Metabolic syndrome is a cluster of various clinical and biochemical abnormalities, needs early diagnosis and treatment to reduce morbidity and mortality. The present study is designed to compare Atherogenic Index of Plasma, Lipid Accumulation Product and Visceral Adiposity Index with metabolic syndrome components in patients with metabolic syndrome. The study comprises of 150 metabolic syndrome patients and 150 age and sex matched healthy controls of both genders in the age group of 20 - 65 years. Atherogenic Index of Plasma, lipid accumulation and Visceral Adiposity Index product index were calculated for all participants. Pearson Correlation was used to compareatherogenic Index of plasma, lipid accumulation and Visceral Adiposity Index product between cases and controls. The receiver operating characteristic curve (ROC) was used to compare the area under the ROC curve (AUC) of Atherogenic Index of Plasma, lipid accumulation and Visceral Adiposity Index product with metabolic syndrome. The comparisons between the BMI, WC, Atherogenic Index of Plasma ,lipid accumulation and Visceral Adiposity Index product were significantly higher in metabolic syndrome cases (p<0.001).Although the entire index were independently associated with Mets, AIP showed the highest area under the curve (0.954, 95% CI 0.929 0.978,p value p<0.0001) in identifying metabolic syndrome.
Identifiants
pubmed: 37693075
doi: 10.6026/973206300181109
pii: 973206300181109
pmc: PMC10484698
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1109-1113Informations de copyright
© 2022 Biomedical Informatics.
Références
Diabetes Care. 2004 May;27(5):1047-53
pubmed: 15111519
Sci Rep. 2021 May 10;11(1):9900
pubmed: 33972652
PLoS One. 2020 Oct 19;15(10):e0240971
pubmed: 33075086
Diabetes Res Clin Pract. 2019 Nov;157:107842
pubmed: 31518658
Clin Med Res. 2020 Dec;18(4):120-125
pubmed: 32340981
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2167-2173
pubmed: 30915762
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
Int J Endocrinol Metab. 2022 Jun 14;20(2):e115428
pubmed: 35993037
Afr Health Sci. 2010 Sep;10(3):248-52
pubmed: 21327136
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102192
pubmed: 34224947
J Family Med Prim Care. 2018 Jan-Feb;7(1):118-123
pubmed: 29915744
Cancer Treat Rev. 2021 Nov;100:102290
pubmed: 34536729
Intern Emerg Med. 2018 Jun;13(4):509-516
pubmed: 29569088
Indian Heart J. 2019 Mar - Apr;71(2):155-160
pubmed: 31280829